$0.89
0.90% yesterday
Nasdaq, Nov 25, 10:00 pm CET
ISIN
US16934W1062
Symbol
CMRX
Sector
Industry

Chimerix, Inc. Stock price

$0.89
+0.02 2.24% 1M
-0.05 4.91% 6M
-0.07 7.34% YTD
-0.08 8.29% 1Y
-5.34 85.68% 3Y
-1.21 57.53% 5Y
-34.11 97.45% 10Y
Nasdaq, Closing price Mon, Nov 25 2024
-0.01 0.90%
ISIN
US16934W1062
Symbol
CMRX
Sector
Industry

Key metrics

Market capitalization $80.21m
Enterprise Value $-54.29m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 0.77
EV/Sales (TTM) EV/Sales -339.31
P/S ratio (TTM) P/S ratio 501.31
P/B ratio (TTM) P/B ratio 0.59
Revenue growth (TTM) Revenue growth -85.98%
Revenue (TTM) Revenue $160.00k
EBIT (operating result TTM) EBIT $-92.83m
Free Cash Flow (TTM) Free Cash Flow $-70.62m
Cash position $136.23m
EPS (TTM) EPS $-0.94
P/E forward negative
P/S forward 84.72
EV/Sales forward negative
Short interest 1.79%
Show more

Is Chimerix, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

Chimerix, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

5 Analysts have issued a Chimerix, Inc. forecast:

5x Buy
100%

Analyst Opinions

5 Analysts have issued a Chimerix, Inc. forecast:

Buy
100%

Financial data from Chimerix, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
0.16 0.16
86% 86%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 20 20
18% 18%
12,750%
- Research and Development Expense 73 73
0% 0%
45,350%
-93 -93
3% 3%
-58,025%
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT -93 -93
3% 3%
-58,016%
Net Profit -84 -84
2% 2%
-52,244%

In millions USD.

Don't miss a Thing! We will send you all news about Chimerix, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Chimerix, Inc. Stock News

Neutral
Seeking Alpha
18 days ago
Chimerix, Inc. (NASDAQ:CMRX ) Q3 2024 Earnings Call November 7, 2024 8:30 AM ET Company Participants Will O'Connor - Investor Relations Mike Andriole - President and Chief Executive Officer Josh Allen - Chief Scientific Officer Michelle LaSpaluto - Chief Financial Officer Allen Melemed - Chief Medical Officer Tom Riga - Chief Operating and Commercial Officer Conference Call Participants Maury R...
Neutral
GlobeNewsWire
25 days ago
DURHAM, N.C., Nov. 01, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced that it will host a live conference call and audio webcast on Thursday, November 7, 2024 at 8:30 a.m. ET to report financial results for the third quarter ended...
Neutral
GlobeNewsWire
about one month ago
DURHAM, N.C., Oct. 18, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), today announced that on October 16, 2024, the Compensation Committee of Chimerix's Board of Directors granted an inducement award to a new employee of non-statutory stock options to purchase up to a total of 130,000 shares of Chimerix's common stock. The Compensation Committee of Chimerix's Board of Directors approved the a...
More Chimerix, Inc. News

Company Profile

Chimerix, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes Brincidofovir for the treatment of adenovirus, cytomegalovirus, and smallpox. The company was founded by George R. Painter, III and Timothy Wollaeger in April 2000 and is headquartered in Durham, NC.

Head office United States
CEO Michael Andriole
Employees 72
Founded 2000
Website www.chimerix.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today